Thymoxamine: A miotic for intraocular use
- 1 March 1986
- journal article
- conference paper
- Published by Springer Nature in Albrecht von Graefes Archiv für Ophthalmologie
- Vol. 224 (2) , 174-178
- https://doi.org/10.1007/bf02141493
Abstract
Thymoxamine hydrochloride can be used intraocularly to reverse phenylephrine or epinephrine mydriasis during intraocular surgery (0.2–0.5 ml of 0.01% or 0.02% solutions proved to be effective). No endothelial damage was found up to a dose of 1 ml of 0.02% thymoxamine in animal experiments using a physiologically buffered solution. Since stability is low in the buffered state, the final concentration has to be prepared at the time of surgery using a 0.5% solution and a phosphate buffer. Intracameral thymoxamine is a potent miotic during operations and can be helpful in extracapsular cataract surgery, keratoplasty, and repair of perforating injuries.This publication has 32 references indexed in Scilit:
- Autonomic Nervous System: Adrenergic AgonistsPublished by Springer Nature ,1984
- Effect of thymoxamine on the human pupilExperimental Eye Research, 1983
- Thymoxamine hydrochloride: An alpha-adrenergic blockerSurvey of Ophthalmology, 1980
- The Use of Thymoxamine in Eyelid RetractionArchives of Ophthalmology (1950), 1979
- Influence of thymoxamine on changes in pupil diameter and accommodation produced by homatropine and ephedrine.British Journal of Ophthalmology, 1976
- Thymoxamine Therapy for Angle-Closure GlaucomaArchives of Ophthalmology (1950), 1973
- Drug therapy of glaucoma.British Journal of Ophthalmology, 1972
- Safe mydriasis.British Journal of Ophthalmology, 1970
- EFFECT OF THYMOXAMINE ON CIRCULATION IN SKIN FLAPS AND IN DENERVATED SKINThe Lancet, 1969
- Competitive blockade of adrenergic α-receptors and histamine receptors by thymoxamineJournal of Pharmacy and Pharmacology, 1965